Physician profile
Ali Etemad-Rezaie
NPI 1679316277
$3,572.54
in general payments reported to CMS, 2019-2025
7 companies · $3,555 in 2025
The $3,555 reported for 2025 was more than what 77% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $17.12 · 2025: $3,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,236 · Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,235.76 |
| Food and Beverage | $1,336.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,474.59 | 2024-2025 | Fast-Fix, Novostitch |
| Arthrex, INC. | $1,357.44 | 2025 | |
| Prodigy Surgical Distribution, INC. | $381.17 | 2025 | |
| Stryker Corporation | $170.78 | 2025 | Na, Salvation, Champion |
| Djo, LLC | $93.75 | 2025 | Aircast, Donjoy |
| Depuy Synthes Sales INC. | $69.56 | 2025 | Tfn-Advance |
| Pinnacle, INC | $25.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Etemad-Rezaie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.